Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments


Sep 2013
The new €2.3 million Europewide ABLADE (Advanced Bladder cancer LAser Diagnostics and thErapy) project – coordinated by the University of Dundee, working with industrial partners – will study whether advanced laser techniques can be used to both detect and treat the disease. The project will develop integrated laser diagnostic and therapeutic techniques exploiting the different ways cancerous and healthy cells respond to certain IR light. The project brings together experts from the university’s Medical School and Photonics and Nanoscience Group, with SPE Lazma Ltd. in Russia and 2M Netherlands BV. The grant comes from the EU’s Marie Curie IAPP (Industry-Academia Partnership & Pathways) program. The four-year project will see staff seconded between the university and the industry partners, and will create four new research posts.

2M NetherlandsABLADEAdvanced Bladder cancer LAser Diagnostics and thErapyBiophotonicsBusinesscancerEuropeIAPPimaginglasersRapidScanSPE LazmaUniversity of Dundee

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!